Novartis Investigative Site

New Brighton, Minnesota 55112

0 studies enrolling now · 2 studies all time

What they study most

Hidradenitis Suppurativa, Moderate to Severe Chronic Plaque-type Psoriasis

Studies at this site

• This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). — Completed
• Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis — Completed